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Social prescribing in
general practice
We know that health and wellbeing is about much more
than medicine. Issues such as loneliness, poverty, phys-
ical inactivity and stress underpin many of the problems
our patients are experiencing, and no drug or clinical
intervention holds the answer. This understanding is
reflected in modern medical theory and education
through the replacement of the traditional biomedical
model of disease with the biopsychosocial model. As
the workload of the NHS shifts towards an increase in
long-term conditions, which now account for 70% of the
total budget spend (NHS England, 2014a), multi-morbid-
ity, mental health problems, obesity and lifestyle-related
diseases; the importance of addressing the psychological
and social determinants of health is clearer than ever.
GPs face these challenges on the front line and aim to
provide holistic care, yet often feel ill-equipped to do so
(Smith, O’Kelly, & O’Dowd, 2010). Attempting to address
complex psycho-social issues within the context of the 10-
minute consultation, already crowded with other agendas
such as the Quality Outcomes Framework, is at best chal-
lenging. At worst, it can feel like opening a can of worms to
which no solutions can be offered. Adopting a medical
model to address symptoms is often quicker, easier and
perhaps perceived as a less risky option. It is what many
doctors were trained to do, and what patients have learned
to expect. All too often this approach results in an unneces-
sary prescription, investigation or referral. In addition to
being ineffective, this approach brings the increased risk of
harm to the patient through side effects, complications and
polypharmacy. In the long term, it can also fuel a disem-
powering cycle of further medicalisation of symptoms and
looking to the healthcare system for solutions (doctor
dependency), rather than promoting self-efficacy and
addressing real-world root causes.
In recent years there has been a broader recognition at
strategic level that the traditional ‘diagnose–treat–cure’
model is outdated and insufficient to address current and
future demands on the health service. The NHS Five Year
Forward View (NHS England, 2014b) proposes shifting
towards a model focusing on much wider individual and
community engagement through three core components:
. Getting serious about prevention
. Empowering patients and
. Engaging communities
Progress has already been made in addressing psycho-
logical needs in the community through initiatives such as
Improving Access to Psychological Therapies, which
makes it quicker and easier for patients to access talking
therapies and psychological interventions such as cogni-
tive behavioural therapy. Going forward, a key part of the
strategy for addressing patients presenting with issues
related to unmet social needs is likely to be the concept
of social prescribing.
What is social
prescribing?
...........................................................
Social prescribing is an umbrella term for a host of stra-
tegies that provide a formal means of enabling primary
care services to refer patients with social, emotional or
practical needs to a range of non-clinical services, often
provided by the voluntary or community sector. A social
prescribing scheme can also help to identify demand and
promote the development of appropriate local services.
Broadly, these services tend to fall into the following
categories:
. Arts and cultural activities
. Physical activity
. Healthy eating, cookery, food preparation
. Befriending
. Learning, educational and volunteering
opportunities
. Financial advice and benefits support
. One-to-one coaching and support
How does it work?
...........................................................
There are various models of social prescribing. At a basic
level, it may consist in providing information about local
services (e.g. display boards/leaflets) with the onus
being on the patient to make contact. GPs themselves
may recommend particular services, with which that they
are familiar and feel will be of value to the patient. In
some cases this is accompanied by a social ‘prescription’
for the intervention, which can lend weight and formality
to the recommendation. Increasingly, however, practices
are making use of dedicated intermediaries known as
facilitators or community navigators. These are usually..
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experienced volunteers with a background in the health,
social or voluntary sector. They may work for a single
practice (usually part-time) or as part of a regional
social prescribing hub/referral centre. Under this
arrangement, the GP triages patients, identifying those
who would benefit from the social support offered by the
community navigator. The navigator is able to spend
more time with individuals to help identify specific
patient needs: for example, arranging a volunteer to
accompany a socially isolated person on their first attend-
ance at a group meetup (which might otherwise feel
intimidating). See Box 1 for examples of UK social pre-
scribing schemes.
Proponents of social prescribing argue that the potential
benefits are substantial and wide-reaching. Service users
benefit from a more holistic approach, aimed at tackling
the root cause of their problems. This can lead to more
self-directed and sustainable solutions, as well as to
fewer unnecessary medical interventions. The health ser-
vice can benefit from a more efficient use of resources,
resulting in cost-saving and freeing of clinicians’ time.
There can also be many more subtle benefits that are
felt in the wider community through having a larger vol-
untary sector engaged in supporting those in need.
Despite such benefits important questions remain. For
some GPs, the concept of social prescribing may sit
uncomfortably with their own health beliefs and views
on the role and responsibilities of a doctor. Others may
fear additional workload at a time when many GPs
already feel overstretched. Similarly, those in the volun-
tary sector may worry about the capacity to cope if there
were an expansion in referrals and whether appropriate
funding and resources would follow. For patients, there is
a risk that some will feel ‘fobbed off’ by their doctor.
There is also a risk that an expansion in social prescribing
would increase the risk of important medical symptoms
being overlooked, leading to diagnostic delay. Ultimately,
however, the biggest challenge is likely to be the issue of
funding, and whether, or to what extent, it is the respon-
sibility of the health service to address society’s non-
medical problems.
In the short term, setting up a social prescribing scheme
will constitute an extra cost to clinical commissioning
groups/practices above that of routine care. To justify
this, schemes will need to demonstrate tangible benefits,
i.e. cost savings. To date much of the evidence gathered
in this area has been for individual initiatives (e.g. refer-
rals to an exercise prescription programme) as opposed
to social prescribing schemes as a whole. A recent review
of social prescribing studies (Kilgarriff-Foster &
O’Cathain, 2015) found that stakeholders viewed social
prescribing as acceptable and feasible, and perceived it
as improving patient wellbeing and reducing use of
health services; however, the report concluded that
there was a dearth of high-quality evidence of effective-
ness and long-term cost-effectiveness.
Demonstrating the effectiveness of ‘softer’ interventions,
such as social prescribing, is notoriously difficult. Many
studies fall foul of the traditional hierarchy of evidence,
which is better suited to measuring ‘hard’ clinical out-
comes, not least because of the fact that the principal
benefits may be long-term, diffuse and perhaps not even
patient-specific. The fact that robust data collection may
not be routine in the third sector poses an additional
challenge. However, in the wake of the NHS 5-year for-
ward view there is already significant work being done to
bolster the evidence base for non-clinical and commu-
nity-based interventions, incorporating broader measures
of value such as wellbeing, NHS sustainability and social
return on investment (NHS England, 2014c).
As with any intervention, social prescribing will not work
for everyone, and will not provide a panacea for society’s
ills, but if we are to overcome the challenges facing the
health service in the 21st century we need to accept that
the divide between medical and social problems is almost
always an artificial one, and that any meaningful solutions
will need to span both domains. Perhaps the greatest
strength of general practice is its capacity to bridge
that divide, and we should embrace social prescribing
as a means to offer more truly holistic solutions to our
patients.
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